Incannex completes option exercise program to raise A$17.66 million; including A$8.20 million from Chief Medical Officer

Clinical stage cannabinoid and psychedelic medicine development company, Incannex Healthcare Limited (ASX: IHL, ‘Incannex’ or the ‘Company’) is pleased to announce the completion of option exercises to raise A$17.66M. The cash balance of the Company is A$22.36M, which positions Incannex in good stead for the continued development and expansion of its pharmaceutical drug and therapy programs.